NasdaqGS - Nasdaq Real Time Price • USD
CytomX Therapeutics, Inc. (CTMX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:05 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 425,393 | 12 |
| Sales | 75,591 | 10 |
| Net Shares Purchased (Sold) | 349,802 | 22 |
| Total Insider Shares Held | 805.89k | -- |
| % Net Shares Purchased (Sold) | 76.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MCCARTHY SEAN A. Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 172,874 | Mar 26, 2024 |
| ROWLAND LLOYD A JR. General Counsel | Sale at price 2.09 per share. | Direct | 10,986 | Mar 19, 2024 |
| MCCARTHY SEAN A. Chief Executive Officer | Sale at price 2.09 per share. | Direct | 42,175 | Mar 19, 2024 |
| OGDEN CHRISTOPHER Officer | Sale at price 2.09 per share. | Direct | 6,196 | Mar 19, 2024 |
| LANDAU JEFFREY B Officer | Sale at price 2.09 per share. | Direct | 13,685 | Mar 19, 2024 |
| BELVIN MARCIA Officer | Sale at price 2.09 per share. | Direct | 26,684 | Mar 19, 2024 |
| ROWLAND LLOYD A JR. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| MCCARTHY SEAN A. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| CHU YU-WAYE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| OGDEN CHRISTOPHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| LANDAU JEFFREY B Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| BELVIN MARCIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 18, 2024 |
| ROWLAND LLOYD A JR. General Counsel | Sale at price 1.38 per share. | Direct | 5,629 | Dec 20, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | Sale at price 1.38 per share. | Direct | 18,710 | Dec 20, 2023 |
| OGDEN CHRISTOPHER Officer | Sale at price 1.38 per share. | Direct | 2,747 | Dec 20, 2023 |
| LANDAU JEFFREY B Officer | Sale at price 1.38 per share. | Direct | 5,628 | Dec 20, 2023 |
| BELVIN MARCIA Officer | Sale at price 1.38 per share. | Direct | 5,628 | Dec 20, 2023 |
| ROWLAND LLOYD A JR. General Counsel | -- | Direct | -- | Dec 15, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | -- | Direct | -- | Dec 15, 2023 |
| OGDEN CHRISTOPHER Officer | -- | Direct | -- | Dec 15, 2023 |
| LANDAU JEFFREY B Officer | -- | Direct | -- | Dec 15, 2023 |
| BELVIN MARCIA Officer | -- | Direct | -- | Dec 15, 2023 |
| ROWLAND LLOYD A JR. General Counsel | Sale at price 1.30 per share. | Direct | 7,135 | Sep 22, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | Sale at price 1.30 per share. | Direct | 18,987 | Sep 22, 2023 |
| LANDAU JEFFREY B Officer | Sale at price 1.30 per share. | Direct | 5,356 | Sep 22, 2023 |
| BELVIN MARCIA Officer | Sale at price 1.30 per share. | Direct | 5,356 | Sep 22, 2023 |
| ROWLAND LLOYD A JR. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 20, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 20, 2023 |
| LANDAU JEFFREY B Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 20, 2023 |
| BELVIN MARCIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 20, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 26,041 | May 19, 2023 |
| JONES ELAINE V Director | Purchase at price 1.55 per share. | Direct | 7,750 | Mar 29, 2023 |
| BELVIN MARCIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 22, 2023 |
| ROWLAND LLOYD A JR. General Counsel | Sale at price 1.98 per share. | Direct | 4,031 | Mar 16, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | Sale at price 1.88 per share. | Direct | 13,391 | Mar 16, 2023 |
| PETERSON AMY C Officer | Sale at price 1.98 per share. | Direct | 8,425 | Mar 16, 2023 |
| CAMPOY CARLOS Chief Financial Officer | Sale at price 1.98 per share. | Direct | 3,459 | Mar 16, 2023 |
| OGDEN CHRISTOPHER Officer | Sale at price 1.98 per share. | Direct | 1,021 | Mar 16, 2023 |
| LANDAU JEFFREY B Chief Financial Officer | Sale at price 1.98 per share. | Direct | 2,923 | Mar 16, 2023 |
| ROWLAND LLOYD A JR. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| MCCARTHY SEAN A. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| OGDEN CHRISTOPHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| LANDAU JEFFREY B Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2023 |
| ROWLAND LLOYD A JR. General Counsel | Sale at price 1.42 per share. | Direct | 7,968 | Jul 20, 2022 |
| HANNAH ALISON L. Officer | Sale at price 1.42 per share. | Direct | 7,965 | Jul 20, 2022 |
| MCCARTHY SEAN A. Chief Executive Officer | Sale at price 1.42 per share. | Direct | 21,206 | Jul 20, 2022 |
| PETERSON AMY C Officer | Sale at price 1.42 per share. | Direct | 10,612 | Jul 20, 2022 |
| CAMPOY CARLOS Chief Financial Officer | Sale at price 1.42 per share. | Direct | 5,617 | Jul 20, 2022 |
| LANDAU JEFFREY B Officer | Sale at price 1.42 per share. | Direct | 5,982 | Jul 20, 2022 |
| ROWLAND LLOYD A JR. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 19, 2022 |
Related Tickers
ASMB Assembly Biosciences, Inc.
12.65
-5.31%
SPRO Spero Therapeutics, Inc.
1.4600
+2.10%
EIGRQ Eiger BioPharmaceuticals, Inc.
2.6700
-12.17%
NXTC NextCure, Inc.
1.3500
+4.65%
ALGS Aligos Therapeutics, Inc.
0.7820
-4.40%
CLRB Cellectar Biosciences, Inc.
3.0300
+0.33%
GLPG.AS Galapagos NV
26.68
+0.45%
TIL Instil Bio, Inc.
10.60
+2.02%
NUVB Nuvation Bio Inc.
2.6800
+2.29%
MGNX MacroGenics, Inc.
14.56
+1.32%